117 related articles for article (PubMed ID: 2147163)
1. Clinical and haemostatic parameters in the HELLP syndrome: relevance of plasminogen activator inhibitors.
Gilabert J; Estellés A; Ridocci F; España F; Aznar J; Galbis M
Gynecol Obstet Invest; 1990; 30(2):81-6. PubMed ID: 2147163
[TBL] [Abstract][Full Text] [Related]
2. Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.
Gilabert J; Estellés A; Aznar J; España F; Andrés C; Santos T; Vallés J
Thromb Haemost; 1990 Jun; 63(3):361-6. PubMed ID: 2144918
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia.
Koh SC; Anandakumar C; Montan S; Ratnam SS
Gynecol Obstet Invest; 1993; 35(4):214-21. PubMed ID: 8330765
[TBL] [Abstract][Full Text] [Related]
4. The HELLP (haemolysis, elevated liver enzymes, low platelet count) syndrome in severe hypertensive crises of pregnancy--does it exist?
Pillay M; Moodley J
S Afr Med J; 1985 Feb; 67(7):246-8. PubMed ID: 3983769
[TBL] [Abstract][Full Text] [Related]
5. Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
Ari E; Yilmaz Y; Gul A; Alahdab YO; Kedrah AE; Macunluoglu B; Aydin A; Arikan H; Ozener C
Am J Reprod Immunol; 2009 Oct; 62(4):238-42. PubMed ID: 19703145
[TBL] [Abstract][Full Text] [Related]
6. [The HELLP syndrome--one hypothesis].
Katsulov A
Akush Ginekol (Sofiia); 1991; 30(2):1-6. PubMed ID: 1883039
[TBL] [Abstract][Full Text] [Related]
7. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
[TBL] [Abstract][Full Text] [Related]
8. Postpartum eclampsia: a recurring perinatal dilemma.
Miles JF; Martin JN; Blake PG; Perry KG; Martin RW; Meeks GR
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):328-31. PubMed ID: 2381609
[TBL] [Abstract][Full Text] [Related]
9. Placental-type plasminogen activator inhibitor in preeclampsia.
de Boer K; Lecander I; ten Cate JW; Borm JJ; Treffers PE
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 1):518-22. PubMed ID: 3126658
[TBL] [Abstract][Full Text] [Related]
10. [The pregnancy at risk and the HELLP syndrome].
Georgiev D; Kabaivanov P; Abadzhiev V
Akush Ginekol (Sofiia); 1991; 30(2):53-8. PubMed ID: 1883049
[No Abstract] [Full Text] [Related]
11. [Changes in fibrinolysis-associated parameters in HELLP syndrome].
Kolben M; Lopens A; Schmitt M; Schneider KT; Graeff H
Geburtshilfe Frauenheilkd; 1994 May; 54(5):257-61. PubMed ID: 8050684
[TBL] [Abstract][Full Text] [Related]
12. Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria.
Belo L; Santos-Silva A; Rumley A; Lowe G; Pereira-Leite L; Quintanilha A; Rebelo I
BJOG; 2002 Nov; 109(11):1250-5. PubMed ID: 12452463
[TBL] [Abstract][Full Text] [Related]
13. HELLP syndrome--a syndrome of hemolysis, elevated liver enzymes and low platelet count--complicating preeclampsia-eclampsia.
Reubinoff BE; Schenker JG
Int J Gynaecol Obstet; 1991 Oct; 36(2):95-102. PubMed ID: 1683323
[TBL] [Abstract][Full Text] [Related]
14. [Clinical outcomes and characteristics of concurrent eclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome].
DI XD; Chen DJ; Liu HS; Kuang JL; Huang DJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):740-4. PubMed ID: 21176553
[TBL] [Abstract][Full Text] [Related]
15. Pre-eclampsia and the HELLP syndrome.
Liaw ST
Aust Fam Physician; 1989 May; 18(5):485, 487, 490. PubMed ID: 2751505
[TBL] [Abstract][Full Text] [Related]
16. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia.
Weinstein L
Obstet Gynecol; 1985 Nov; 66(5):657-60. PubMed ID: 4058824
[TBL] [Abstract][Full Text] [Related]
17. Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-based agglutination.
Proietti AB; Johnson MJ; Proietti FA; Repke JT; Bell WR
Obstet Gynecol; 1991 May; 77(5):696-700. PubMed ID: 2014082
[TBL] [Abstract][Full Text] [Related]
18. Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
Molvarec A; Prohászka Z; Nagy B; Kalabay L; Szalay J; Füst G; Karádi I; Rigó J
J Reprod Immunol; 2007 Apr; 73(2):172-179. PubMed ID: 17023052
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
Estellés A; Gilabert J; España F; Aznar J; Galbis M
Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia.
Cadroy Y; Grandjean H; Pichon J; Desprats R; Berrebi A; Fournié A; Boneu B
Br J Obstet Gynaecol; 1993 May; 100(5):416-20. PubMed ID: 8518239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
